Evidence from both GWAS and clinical observation has suggested that certain psychiatric, metabolic, and 10 autoimmune diseases are heterogeneous, comprising multiple subtypes with distinct genomic etiologies and 11 Polygenic Risk Scores (PRS). However, the presence of subtypes within many phenotypes is frequently 12 unknown. We present CLiP (Correlated Liability Predictors), a method to detect heterogeneity in single 13 GWAS cohorts. CLiP calculates a weighted sum of correlations between SNPs contributing to a PRS on 14 the case/control liability scale. We demonstrate mathematically and through simulation that among i.i.d. 15 homogeneous cases, significant anti-correlations are expected between otherwise independent predictors due 16 to ascertainment on the hidden liability score. In the presence of heterogeneity from distinct etiologies, 17 confounding by covariates, or mislabeling, these correlation patterns are altered predictably. We further 18 extend our method to two additional association study designs: CLiP-X for quantitative predictors in 19 applications such as transcriptome-wide association, and CLiP-Y for quantitative phenotypes, where there 20 is no clear distinction between cases and controls. Through simulations, we demonstrate that CLiP and its 21 extensions reliably distinguish between homogeneous and heterogeneous cohorts when the PRS explains as 22 low as 5% of variance on the liability scale and cohorts comprise 50, 000 − 100, 000 samples, an increasingly 23 practical size for modern GWAS. We apply CLiP to heterogeneity detection in schizophrenia cohorts totaling 24 > 50, 000 cases and controls collected by the Psychiatric Genomics Consortium. We observe significant 25 heterogeneity in mega-analysis of the combined PGC data (p-value 8.54e-4), as well as in individual cohorts 26 meta-analyzed using Fisher's method (p-value 0.03), based on significantly associated variants. 27 2 1 Introduction 28
, SNPs are uniformly ascertained, but negative correlations exist between any pair of associated SNPs. For heterogeneous cases comprising a mixture of true cases and misclassified controls (C,D), SNPs are ascertained in a subset of individuals, creating positive correlations between SNPs. For heterogeneous cases comprising disjoint sub-phenotypes (E,F,G), associated SNP subsets S 1 and S 2 pertain to two independent PRSs, and passing the threshold of at least one of these PRSs is sufficient to select a case (E). Genotypes sampled from this model produce a mixture of positive and negative correlations.
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(CLiP-X), and also with quantitative phenotypes for which there is no definition of a "case" (CLiP-Y). Next 135 we describe the generative process for simulations of homogeneous and heterogeneous PRS data used to test 136 the performance of these methods. are sampled independently, but is included below for clarity. This modified heterogeneity score is computed 146 as follows:
The score S het is a weighted sum of difference in correlation between cases and controls, to account for 
To generate cases and controls, we iteratively generate batches of transcripts by random sampling, and 181 compile those that pass or fail the threshold cutoff into case and control cohorts. We generate heterogeneous 182 cohorts, by concatenating simulated cases and controls, with the fraction of cases π set to 0.5 for simplicity.
183
We reasoned that this procedure was a conservative representation of a large number of possible heterogeneity 184 scenarios including those with multiple independent sub-phenotypes. If the PRSs of these sub-phenotypes 185 are independent, then a large number of correlations between predictors will be evaluated close to zero, 
Characterizing correlations between continuous variables 191
Given N × L matrices of quantitative expression measurements Z among cases and Z 0 among controls, we would like to determine whether Z comprises a homogeneous or heterogeneous set of cases as generated in Supplemental Algorithm 1. When Z is heterogeneous, we assume the individuals in Z can be assigned to one of two subtypes: one sampled according to the liability threshold model for the simulated phenotype, and one sampled randomly as controls. For a given predictor indexed by j ∈ [1, . . . , L], assume Z ij is sampled according to a mean and variance specific to the subtype of individual i, denoted by Z + i· for the case subtype and Z − i· for the control subtype. The distribution of the variables need not be discrete or even normally distributed, as the heterogeneity score is computed from correlations, which in turn rely only on the mean and variance of the input variables. Therefore the score can be calculated assuming any probability distribution provided that the mean and standard deviation are obtainable. For an arbitrary probability distribution D parameterized by its mean and standard deviation, we have:
Assume that the proportion of individuals belonging to the group + is π. For a homogeneous group of 192 case, π = 0, and our simulations assume π = 0.5, but in practice this proportion is unknown. Incorporating 
Definition of weights for continuous variables 198
We would like to make use of these expectations over correlations by incorporating them as weights in the 199 heterogeneity score as in Han et al. [30] . As predictors with high mean differences between subgroups and 200 high effects are expected to contribute more signal to the score, weighting them higher than other predictors 201 will increase power to detect heterogeneity. Therefore, we would like to define a set of weights w ij for each 202 expected r ij .
203
We derive the weights for continuous variables in an analogous manner to Han et al. [30] , by taking 204 11 the derivative of the expected sample correlation with respect to π at the null value, π = 0.
To facilitate calculation of score. We demonstrate in the Results that theoretically and by simulation this assumption is violated in 211 logistic and liability threshold models.
212
Given the assumption of no correlation within subgroups, the correlation between two variables Z ·j 213 and Z ·k can be expressed as the following. For further details on the derivation, please see the Supplemental   214 Note.
The same weights defined in Han et al. [30] for Bernoulli variables is a special case of this general 216 formulation. These weights can now be substituted into the heterogeneity score.
217
In practice we do not know the value of µ + j because the membership of individuals in each of the 218 subsets is unknown. However, we do know the mean values of the heterogeneous case group which we denote 219 as µ j . We can use this value as an approximation for µ + j , and calculate an approximate weight:
We can also quantify the errors we are making by this approximation. We have the following rela-
The approximation in Eq. 10 will attenuate the magnitude of µ + j with respect to the true value of the 223 weight. However, we also see that:
As each weight is scaled by a constant factor, their relative magnitudes are unchanged. We define a weight over individuals such that those with higher phenotype values contribute more strongly to the heterogeneity score. For a cohort of N individuals let X ij ∈ {0, 1, 2} be the number of risk alleles of SNP j in individual i, and let Y = (y 1 , . . . , y N ) values of quantitative trait 1 for the respective individuals. We introduce a normalized weight vector across the N individuals defined as φ ∈ R N such that ∀i, φ i ≥ 0 and N i φ i = 1. Most intuitively we would define φ ≡ φ(F), where the weight values would reflect normalized scaling of the trait φ i = F (yi) j F (yj ) by a monotone function F. Dichotomous, case/control weighting is the special case of: SNP j, we define the weighted mean value across N individuals as:
Between two SNPs j and k, we define the weighted covariance as:
15
We define the weighted correlation matrix R φ for any weighting φ as:
The heterogeneity score tallies the entries of the upper-triangular correlation matrix for the phenotype-276 weighted individuals R φ(F ) . As we now lack a held-out set of controls to cancel the contribution of correla-277 tions unrelated to the phenotype, we instead calculate a conventional correlation uniformly weighted across 278 all individuals R 0 ≡ R φ(F 1 ) . Additionally, we introduce a scaling factor of (
the change in variance resulting from re-weighting the correlation according to individual weights φ i . These 280 changes produce the following preliminary heterogeneity score for quantitative phenotypes: 
. The contribution of SNP j to the heterogeneity score is then scaled by
where
is a weighted generalization of an odds ratio. These weights are analogous to those found in Han et al. [30] , 289 where given case allele frequency p + j , control allele frequency p 0 j , and sample odds ratio
.
292
Combining these intermediate calculations, the heterogeneity test statistic for continuous phenotypes 293 is:
For high N , this test statistic approaches the standard normal distribution, and can be evaluated as 295 a z-score hypothesis test.
296
Note that even when applying a dichotomous weighting scheme, dividing the cohort with quantita-297 tive phenotypes into artificial cases and controls, CLiP-Y still differs slightly from a direct application of 298 the case/control score. If a dichotomous weight function produces N φ artificial cases, the scaling factor
This corrects for the slight reduction in variance of R φ jk − R 0 jk because these differently-weighted correlations 301 are taken over a single cohort of individuals rather than disjoint sets of cases and controls. In practice, we 302 find this correction factor performs very well in scaling the test statistic variance to 1. 303 2.6 Evaluating heterogeneity in SCZ 304 We applied CLiP to test for heterogeneity in case/control data for schizophrenia collected by the Psychiatric 305 Genomics Consortium (PGC). The data comprise in total roughly 23,000 cases and 28,000 controls and 306 was the subject of a 2014 meta-analysis reporting 108 schizophrenia-associated loci [31] . We would like to 307 test whether heterogeneity suggested from clinical observation is also detectable at the level of the PRS 308 comprising these loci. The PGC data is an aggregate of cohorts collected from many studies conducted 309 in different populations. Therefore a test for heterogeneity over the all cohorts is likely to be confounded 310 by ancestry stratification or batch effects between cohorts. We attempt to circumvent these confounding 
where K is the total number of cohorts and p i is the p-value of the CLiP heterogeneity score for 317 cohort i. The p-value of this test statistic is evaluated on a chi-square distribution with 2K degrees of 318 freedom. Additionally, we calculated the meta-analysis Z-score of the CLiP score in a manner analogous to 319 the conventional GWAS approach, but with a 1-tail test for highly positive scores only. The meta-analysis 320 Z score is calculated according to
where Z CLiP is the CLiP Z-score evaluated against the expected score with a standard deviation of 322 1, and n i is the sample size of cohort i. according to a fixed risk-allele frequency of p = 0.2. Effect sizes are set to a fixed value producing the desired 372 variance explained in a standard normal PRS distribution. Homogeneous case cohorts were generated by 373 repeatedly sampling control genotypes and selecting individuals whose PRS pass a threshold corresponding 374 to a prevalence of 0.01. Heterogeneous cohorts are created by combining an equal number of homogeneous 375 cases and controls. The scores of these cohorts were evaluated over a range of sample sizes keeping variance 376 explained constant at 0.034 ( Figure 2B) , and a range of total variance explained keeping sample size constant 377 at 30,000 cases and 30,000 controls ( Figure 2C ). Additionally, we tested the performance of CLiP with respect 378 to the fraction of individuals in the case mixture that are true cases, shown in in Figure 3A . The color of 379 each line indicates the size of the entire case cohort, while the X-axis indicates the fraction of individuals of 380 20 that count that are true cases. When the fraction is 0, the cohort contains only controls, and all expected 381 correlations are 0, producing a heterogeneity score of 0. When the fraction is 1, the cohort contains only 382 cases, and produces a highly negative score due to negative correlations between all pairs of SNPs. As 383 expected, a mixture of cases and controls produces positive scores, with the peak score occurring when the 384 cohort is split evenly. More detailed results of this set of simulations are shown in Supplemental Table S2 . Thresholded models for case/control data such as logistic and probit (liability threshold) regression produce negative correlations between predictors, while the simpler multiplicative (Risch) model does not. Here case/control cohorts are generated from logistic or Risch models with 10 diploid SNPs with allele frequency 0.5 and OR 1.16 (set to keep Risch probabilities ≤ 1). As described in [30] , Risch model cases exhibit no correlations in homogeneous cases, and positive correlations in heterogeneous cases, producing zero and positive heterogeneity scores, respectively. However, in thresholded models, negative correlations in homogeneous models produce negative scores. This negative bias in homogeneous scores is unaccounted for in the method by [30] , significantly increasing the probability of type II errors. (B) Heterogeneity scores (y-axis) on simulated case/control cohorts as a function of sample size (x-axis) with a fixed variance explained of 0.034 as in [31] . Simulations are run with a PRS of 100 SNPs with total variance explained of 0.034. Heterogeneous cohorts (Green) are equal-proportion mixtures of controls (Black) and homogeneous cases (Red). The expected homogeneous score (Blue) is calculated from effect sizes and allele frequencies of PRS SNPs only, and should be used as the true null score in CLiP. (C) Heterogeneity scores (y-axis) as a function of variance explained (x-axis) with a fixed sample size of 30,000 cases and 30,000 controls.
We also evaluated the performance of CLiP when heterogeneity consists of multiple potentially inde-386 pendent sub-phenotypes, each with a distinct PRS, such that an individual is considered to be a case when 387 it is a case for one or more of these sub-phenotypes. Discovering heterogeneity in these cohorts is more 388 challenging because correlations between SNPs involved in different sub-phenotype PRSs are expected to 389 be zero rather than positive, and if there are any SNP associations shared between sub-phenotypes, nega-390 21 tive correlations will be expected between them despite the presence of distinct sub-phenotypes. We tested 391 the performance of CLiP by fixing the number of cases and controls at 50,000 each, the total number of 392 SNPs at 100, and the total variance explained at 0.05, while varying the number of sub-phenotypes and the 393 fraction of SNPs that are shared across all sub-phenotypes. When this fraction is zero, the sub-phenotypes 394 are completely independent, and the SNPs are divided into mutually exclusive subsets associated with each 395 sub-phenotype. When the fraction is non-zero, that fraction of SNPs has the same effect size across all 396 sub-phenotypes. Results of these simulations are shown in Figure 3B as well as Supplemental Table S1 .
397
Note that by dividing associated SNPs into associations with particular sub-phenotypes, the total variance 398 explained for each sub-phenotype is reduced, and the observed variance explained of the entire heterogeneous 399 cohort will be lower in a simple linear regression. Figure 4 : A Learned weight functions φ(x) for scoring heterogeneity in quantitative phenotypes. A local search over polynomial coefficients is performed such that the resulting function maximizes the difference between the heterogeneity scores of simulated samples of homogeneous and heterogeneous cohorts. B Tests for heterogeneity in quantitative phenotypes using multiple weighting functions over individuals, including those in A, as a function of variance explained by the PRS. Plotted are scores of heterogeneous cohorts minus the expected score of a homogeneous cohort over 20 trials. One Hundred SNPs are simulated with cohorts of 100,000 individuals. C Tests for heterogeneity in quantitative phenotypes using multiple weight functions. Plotted are mean scores of heterogeneous cohorts minus the expected score of a homogeneous cohort over 20 trials, as a function of sample size. One hundred SNPs are simulated with a total variance explained of 0.1. For comparison these scores are plotted on the same Y-axis as scores generated from step function weights at various thresholds on the percentile scale of a standard normal quantitative phenotype distribution. For each of these step function scores, the expected homogeneous score is estimated by the mean of 20 sampled homogeneous cohorts, to limit computation time. Figure SS2 . Controls (Black) have no criteria for selection placed on their generated quantitative predictors; homogeneous cases (Red) are selected according to a liability threshold over predictors; and heterogeneous cases (Green) are an even combination of controls and homogeneous cases. The Blue line indicates expected mean scores of homogeneous cohorts calculated from summary statistics of the quantitative predictors. As with discrete SNPs, quantitative predictors are negatively correlated among homogeneous cases.
Shown in Figure 5 are results with a sample size of 100,000 and a total variance explained of h 2 E = 0.05 438 by quantitative predictors. We observe that for all sample sizes, the heterogeneity score is approximately Figure 6 : CLiP heterogeneity scores evaluated over single cohorts in the PGC schizophrenia data set, plotted by the number of genotyped cases. The black line denotes the expected score given summary statistics reported in [31] and sample sizes specific to each cohort, and the shaded region denotes z-score thresholds corresponding to particular p-values of significance.
Discussion

464
We present a general framework for identifying hidden heterogeneity among cases for multiple phenotypes 465 by observing correlations between genotypes. Specifically, we derive modified test statistics to account 466 for non-genotype input variables such as expression data, which may be continuous and sampled from 467 any distribution with known mean and variance. Additionally, we allow for heterogeneity to be scored in 468 quantitative phenotypes, that lack the clear-cut ascertainment of cases vs. controls that facilitates a simple Table 1 : CLiP heterogeneity scores for individual cohorts and their combination. Cohorts with an asterisk have had a SNP excluded which has zero variance within either the case or control cohort, resulting in an undefined correlation. An FDR of 1 3 was used for Benjamini-Hochberg analysis.
28 with each disease are themselves homogeneous.
